Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

The patients have stage IB-IIIA NSCLC.
Patient ages are ≥ 18 years old, regardless of gender.
The patients have an ECOG ps of 0-1, with a condition suitable for surgery.
The patients have not received any anti-tumor treatment.
The patients have adequate blood function.
The patients have adequate organ function.
The patients had been using an appropriate method of contraception, and there exists a negative pregnancy test (serum or urine) for women.
The patients will give their signed informed consent.

Patients who had a prior allogeneic tissue or organ transplantation.
Patients who have multiple cancers.
Patients who have any severe or uncontrolled systemic diseases.
Patients with a positive test for HIV, HBV, or HCV.
Patients with severe infection or with an infection that required antibiotic therapy.
Patients with a history of interstitial lung disease, active tuberculosis, or autoimmune disease.
Patients who have participated in any other clinical trials.
Patients who are considered ineligible by the investigator.

Neoadjuvant Camrelizumab, Nab-paclitaxel and Carboplatin in Stage IB-IIIA NSCLC